CG
AKCA

Cutler Group’s Akcea Therapeutics Inc AKCA Stock Holding History

Cutler Group’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,899
Closed -$27K – 5159
2020
Q1 		$27K Buy
1,899
+1,399
+280% +$23K ﹤0.01% 2120
2019
Q4 		$8K Sell
500
-3,000
-86% -$55.8K ﹤0.01% 2804
2019
Q3 		$53K Buy
3,500
+3,300
+1,650% +$70.3K ﹤0.01% 1505
2019
Q2 		$4K Buy
+200
New +$4.94K ﹤0.01% 3309
2018
Q4 		– Sell
-400
Closed -$11.2K – 4902
2018
Q3 		$14K Hold
400
– – ﹤0.01% 2479
2018
Q2 		$9K Buy
400
+273
+215% +$6.52K ﹤0.01% 2775
2018
Q1 		$3K Buy
+127
New +$2.73K ﹤0.01% 3669

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Cutler Group's AKCA Position: Q2 2020 in Review

Cutler Group sold out of Akcea Therapeutics Inc (AKCA) in Q2 2020, closing a stake of 1,899 shares — an estimated $27K sold.

Cutler Group first reported a position in AKCA in Q1 2018 and held it in 7 quarters. The position peaked at $53K in Q3 2019. 84 funds tracked by Wall St. Rank hold AKCA as of Q2 2020.

  • Cutler Group reported no remaining Akcea Therapeutics Inc position as of Q2 2020 after selling out during the quarter.
  • Cutler Group sold 1,899 Akcea Therapeutics Inc shares in Q2 2020, an estimated $27K.
  • Cutler Group first reported a position in Akcea Therapeutics Inc in Q1 2018 and held it in 7 quarters.
  • Cutler Group's Akcea Therapeutics Inc position peaked at $53K in Q3 2019.
  • 84 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q2 2020.

Based on Cutler Group's 13F filing for Q2 2020, filed 22 Jul 2020.